GDX012

· Takeda

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GDX012, covering 2026-04-01 to 2026-04-01. Get the full timeline:

Most recent: Clinical Trial Update: A Study of GDX012 in Adults With Relapsed or Refractory Acute Myeloid Leukemia [Phase 1, Phase 2]